Stelara
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Stelara in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Stelara.
8
Global Revenue Ranking
Recent articles on PMLiVE featuring Stelara
Avtozma IV now fully aligns with all indications covered by Actemra IV in the US
An estimated 32 million people aged 50 years and over in Europe were living with osteoporosis in 2019
The Stelara biosimilar now offers all dosage forms and strengths of its reference product
Approximately 25% of cases are diagnosed during childhood or adolescence
Inflammatory bowel disease is estimated to affect nearly two million people across Europe
An estimated three million people in the US are affected by inflammatory bowel disease
Tremfya, Stelara and Darzalex have been recommended for ulcerative colitis, Crohn’s disease and multiple myeloma, respectively
The drug has been approved for rheumatoid arthritis, giant cell arteritis and other indications
The drug has been approved to treat plaque psoriasis, psoriatic arthritis and Crohn’s disease
Inflammatory bowel disease affects almost one in every 100 people in the US
The drug has been authorised for use in gastroenterology, dermatology and rheumatology indications
Epysqli has been authorised to treat paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology